Ftse Mib
34.335,29
0,44%
DAX
20.024,66
0,58%
S&P 500
5.845,99
-0,61%
NASDAQ
19.240,59
-0,36%
Bitcoin
96.468,26
2,20%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Xenon Pharmaceuticals Inc (XENE) Xenon Pharmaceuticals Inc (XENE) Notizie

Xenon Pharmaceuticals Inc

XENE
41,295
2,10 (5,34%)
Ultimo aggiornamento: 18:31:17
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202423:50EDGAR2Form 144 - Report of proposed sale of securities
06/12/202422:01GLOBEXenon Showcases New Long-Term Azetukalner Data from X-TOLE..
25/11/202414:30GLOBEXenon to Showcase New Long-Term Azetukalner Data at AES 2024
13/11/202422:01GLOBEXenon to Present at Upcoming Investor Conferences
12/11/202422:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:09EDGAR2Form 8-K - Current report
12/11/202422:01GLOBEXenon Reports Q3 2024 Financial Results and Business Update
05/11/202422:01GLOBEXenon to Report Q3 2024 Financial Results on November 12,..
02/10/202422:28GLOBEXenon to Present at BofA Securities 2024 CNS Therapeutics..
09/9/202414:30GLOBEXenon Showcases Azetukalner Data at 15th European Epilepsy..
12/8/202414:30GLOBEXenon Expands Leadership Team with Matthew D. Ronsheim,..
09/8/202422:57EDGAR2Form S-3ASR - Automatic shelf registration statement of..
08/8/202422:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:08EDGAR2Form 8-K - Current report
08/8/202422:01GLOBEXenon Reports Q2 2024 Financial Results and Business Update
01/8/202422:01GLOBEXenon to Report Q2 2024 Financial Results on August 8, 2024
13/7/202403:44EDGAR2Form 144 - Report of proposed sale of securities
12/6/202423:32EDGAR2Form 144 - Report of proposed sale of securities
05/6/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202423:30EDGAR2Form 144 - Report of proposed sale of securities
05/6/202422:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/6/202422:12EDGAR2Form 8-K - Current report
05/6/202422:01GLOBEXenon Pharmaceuticals to Present at the Goldman Sachs 45th..
28/5/202414:30GLOBEXenon Pharmaceuticals Presents Data from Phase 2 X-NOVA..
09/5/202422:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:09EDGAR2Form 8-K - Current report
09/5/202422:01GLOBEXenon Pharmaceuticals Reports First Quarter 2024 Financial..
08/5/202422:01GLOBEXenon Pharmaceuticals to Present at the BofA Securities..
07/5/202422:01GLOBEXenon Pharmaceuticals to Present at the 2024 RBC Capital..
02/5/202422:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
16/4/202414:30GLOBEXenon Pharmaceuticals Showcases XEN1101 at the American..
04/4/202422:01GLOBEXenon Pharmaceuticals to Present at the 23rd Annual Needham..
12/3/202421:01GLOBEXenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS..
09/3/202400:47EDGAR2Form 144 - Report of proposed sale of securities
08/3/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:27EDGAR2Form 8-K - Current report
08/3/202401:04EDGAR2Form 144 - Report of proposed sale of securities
08/3/202401:03EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:01GLOBEXenon Pharmaceuticals to Present at Leerink Partners Global..
29/2/202422:10EDGAR2Form 8-K - Current report
29/2/202422:01GLOBEXenon Pharmaceuticals Reports Fourth Quarter and Full Year..
22/2/202422:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
14/2/202415:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202414:00GLOBEXenon Pharmaceuticals Outlines Key Milestone Opportunities..
03/1/202414:30GLOBEXenon Pharmaceuticals to Present at the 42nd Annual J.P...
Apertura: 39,885 Min: 39,64 Max: 42,23
Chiusura: 39,20

La tua Cronologia

NASDAQ
XENE
Xenon Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network